PharmaCoNets of Revefenacin (SPCN: 59.91 )

Drug NamePathway IDPathway nameP-valueNo. of gene membersUniProt ACGene nameDetail of Coexpression
Revefenacinhsa00030Pentose phosphate pathway4.69E-044P60891, P51854, P52209, P37837PRPS1, TKTL1, PGD, TALDO1More
Revefenacinhsa00220Arginine biosynthesis1.85E-032P05089, P49448ARG1, GLUD2More
Revefenacinhsa00310Lysine degradation3.15E-022Q96KQ7, P51648EHMT2, ALDH3A2More
Revefenacinhsa00500Starch and sucrose metabolism9.35E-033O43451, P46976, P06737MGAM, GYG1, PYGLMore
Revefenacinhsa00510N-Glycan biosynthesis3.15E-022P15907, Q9NR34ST6GAL1, MAN1C1More
Revefenacinhsa00520Amino sugar and nucleotide sugar metabolism2.24E-023Q16222, Q9Y223, P06865UAP1, GNE, HEXAMore
Revefenacinhsa00600Sphingolipid metabolism3.76E-021P15289ARSAMore
Revefenacinhsa00630Glyoxylate and dicarboxylate metabolism1.13E-022P40925, P15104MDH1, GLULMore
Revefenacinhsa00830Retinol metabolism3.93E-023P00352, Q9BPW9, O75911ALDH1A1, DHRS9, DHRS3More
Revefenacinhsa00983Drug metabolism - other enzymes2.45E-023P20839, P32320, P05164IMPDH1, CDA, MPOMore
Revefenacinhsa01230Biosynthesis of amino acids2.19E-024P51854, P60891, P05089, P37837TKTL1, PRPS1, ARG1, TALDO1More
Revefenacinhsa01521EGFR tyrosine kinase inhibitor resistance1.82E-021P08069IGF1RMore
Revefenacinhsa01522Endocrine resistance2.16E-021P08069IGF1RMore
Revefenacinhsa01523Antifolate resistance1.68E-022Q92820, P04818GGH, TYMSMore
Revefenacinhsa02010ABC transporters4.48E-021Q8IZY2ABCA7More
Revefenacinhsa03040Spliceosome2.10E-0410O60508, P08579, P26368, Q13595, Q01130, P84103, Q13243, P11142, Q9Y2W2, O75643CDC40, SNRPB2, U2AF2, TRA2A, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, ASCC3L1More
Revefenacinhsa03430Mismatch repair4.38E-021P20585MSH3More
Revefenacinhsa04010MAPK signaling pathway4.15E-021P08069IGF1RMore
Revefenacinhsa04014Ras signaling pathway3.65E-021P08069IGF1RMore
Revefenacinhsa04015Rap1 signaling pathway5.18E-043P08069, P06213, O00522IGF1R, INSR, KRIT1More
Revefenacinhsa04060Cytokine-cytokine receptor interaction5.34E-0311P14784, P27930, P14778, P26842, Q06643, Q13651, P25024, Q9UBD3, P47992, P09341, P01730IL2RB, IL1R2, IL1R1, CD27, LTB, IL10RA, CXCR1, XCL2, XCL1, CXCL1, CD4More
Revefenacinhsa04061Viral protein interaction with cytokine and cytokine receptor1.32E-026P09341, P25024, P47992, Q9UBD3, Q13651, P14784CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RBMore
Revefenacinhsa04062Chemokine signaling pathway6.73E-039P25024, P09341, P47992, Q9UBD3, P07948, P63218, P50151, P43250, Q08881CXCR1, CXCL1, XCL1, XCL2, LYN, GNG5, GNG10, GRK6, ITKMore
Revefenacinhsa04064NF-kappa B signaling pathway3.17E-0714P10415, O00463, P14778, P01375, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, P09341, Q06643BCL2, TRAF5, IL1R1, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, CXCL1, LTBMore
Revefenacinhsa04066HIF-1 signaling pathway2.16E-021P08069IGF1RMore
Revefenacinhsa04068FoxO signaling pathway1.99E-021P08069IGF1RMore
Revefenacinhsa04110Cell cycle6.63E-046P06493, O60566, P30304, P33981, P42773, P01106CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYCMore
Revefenacinhsa04114Oocyte meiosis2.99E-021P08069IGF1RMore
Revefenacinhsa04140Autophagy - animal9.37E-036P08069, P22694, Q14643, P10415, Q9H1Y0, Q04759IGF1R, PRKACB, ITPR1, BCL2, ATG5, PRKCQMore
Revefenacinhsa04142Lysosome2.01E-036P22304, P38571, Q13510, Q9UJJ9, P07602, P49279IDS, LIPA, ASAH1, GNPTG, PSAP, SLC11A1More
Revefenacinhsa04144Endocytosis1.09E-0312Q13191, P0DMV8, P11142, Q9H444, P62491, P25024, P43250, Q8WU79, Q14161, P14784, Q9UMY4, Q9Y5X3CBLB, HSPA1A, HSPA8, CHMP4B, RAB11A, CXCR1, GRK6, SMAP1L, GIT2, IL2RB, SNX12, SNX5More
Revefenacinhsa04145Phagosome3.69E-027O75015, Q15080, P05164, P78380, O60603, P35443, P13765FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOBMore
Revefenacinhsa04150mTOR signaling pathway2.32E-021P08069IGF1RMore
Revefenacinhsa04152AMPK signaling pathway1.99E-021P08069IGF1RMore
Revefenacinhsa04211Longevity regulating pathway2.16E-021P08069IGF1RMore
Revefenacinhsa04213Longevity regulating pathway - multiple species9.98E-033P08069, Q08828, P0DMV8IGF1R, ADCY1, HSPA1AMore
Revefenacinhsa04270Vascular smooth muscle contraction1.53E-024P0DP23, Q08828, P35579, P35318CALM1, ADCY1, MYH9, ADMMore
Revefenacinhsa04340Hedgehog signaling pathway3.93E-023P22694, Q13635, P10415PRKACB, PTCH1, BCL2More
Revefenacinhsa04510Focal adhesion3.48E-021P08069IGF1RMore
Revefenacinhsa04520Adherens junction8.29E-031P08069IGF1RMore
Revefenacinhsa04550Signaling pathways regulating pluripotency of stem cells1.99E-021P08069IGF1RMore
Revefenacinhsa04610Complement and coagulation cascades1.14E-052P00734, P0C0L4F2, C4AMore
Revefenacinhsa04612Antigen processing and presentation2.02E-038P13765, P48382, P01730, P26715, P26717, Q13241, P01732, P01375HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A, TNFMore
Revefenacinhsa04640Hematopoietic cell lineage1.56E-0513P13612, P14778, P27930, P15144, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375ITGA4, IL1R1, IL1R2, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNFMore
Revefenacinhsa04650Natural killer cell mediated cytotoxicity6.35E-0610P01375, P06239, O60880, P20963, Q13241, P26718, O14931, O75015, P26717, P26715TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1More
Revefenacinhsa04658Th1 and Th2 cell differentiation9.50E-1413Q04759, P07766, P20963, P09693, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761PRKCQ, CD3E, CD247, CD3G, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3More
Revefenacinhsa04659Th17 cell differentiation1.13E-1115Q04759, Q16539, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, Q13485, P08238, P07766, P09693, P20963PRKCQ, MAPK14, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD4, HSP90AB1, CD3E, CD3G, CD247More
Revefenacinhsa04660T cell receptor signaling pathway2.23E-0915P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3BMore
Revefenacinhsa04662B cell receptor signaling pathway4.07E-024P42338, P60033, P07948, Q8N149PIK3CB, CD81, LYN, LILRA2More
Revefenacinhsa04724Glutamatergic synapse2.22E-024O15399, P63218, P50151, P15104GRIN2D, GNG5, GNG10, GLULMore
Revefenacinhsa04727GABAergic synapse4.42E-023P63218, P50151, P15104GNG5, GNG10, GLULMore
Revefenacinhsa04728Dopaminergic synapse3.91E-025P50151, P49841, Q16539, P49407, P48058GNG10, GSK3B, MAPK14, ARRB1, GRIA4More
Revefenacinhsa04730Long-term depression1.16E-021P08069IGF1RMore
Revefenacinhsa04912GnRH signaling pathway3.19E-023Q08828, Q9Y6R4, P0DP23ADCY1, MAP3K4, CALM1More
Revefenacinhsa04913Ovarian steroidogenesis8.40E-042P06213, P08069INSR, IGF1RMore
Revefenacinhsa04914Progesterone-mediated oocyte maturation2.16E-021P08069IGF1RMore
Revefenacinhsa04915Estrogen signaling pathway6.42E-034Q08828, P0DMV8, P0DP23, Q15788ADCY1, HSPA1A, CALM1, NCOA1More
Revefenacinhsa04923Regulation of lipolysis in adipocytes3.76E-021P06213INSRMore
Revefenacinhsa04924Renin secretion4.69E-022P07550, P0DP23ADRB2, CALM1More
Revefenacinhsa04930Type II diabetes mellitus3.14E-021P06213INSRMore
Revefenacinhsa04960Aldosterone-regulated sodium reabsorption3.14E-021P06213INSRMore
Revefenacinhsa04964Proximal tubule bicarbonate reclamation4.48E-021P00918CA2More
Revefenacinhsa04966Collecting duct acid secretion4.48E-021P00918CA2More
Revefenacinhsa04970Salivary secretion1.60E-023P07550, Q08828, P0DP23ADRB2, ADCY1, CALM1More
Revefenacinhsa05017Spinocerebellar ataxia2.22E-024Q92915, O15399, P42338, P21796FGF14, GRIN2D, PIK3CB, VDAC1More
Revefenacinhsa05120Epithelial cell signaling in Helicobacter pylori infection1.41E-024Q16539, P09341, P25024, P25025MAPK14, CXCL1, CXCR1, CXCR2More
Revefenacinhsa05133Pertussis2.35E-032P0DP23, P0C0L4CALM1, C4AMore
Revefenacinhsa05140Leishmaniasis3.53E-026P13612, O75015, P13765, O60603, P01375, Q15080ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, NCF4More
Revefenacinhsa05143African trypanosomiasis4.81E-022P69905, P68871HBA2, HBBMore
Revefenacinhsa05144Malaria1.14E-025P60033, O60603, P01375, P35443, P26718CD81, TLR2, TNF, THBS4, KLRK1More
Revefenacinhsa05146Amoebiasis1.65E-069P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSGMore
Revefenacinhsa05150Staphylococcus aureus infection1.31E-022P0C0L4, P13646C4A, KRT13More
Revefenacinhsa05163Human cytomegalovirus infection1.63E-027P50151, P49841, P14778, Q13651, P25025, Q16539, O00463GNG10, GSK3B, IL1R1, IL10RA, CXCR2, MAPK14, TRAF5More
Revefenacinhsa05169Epstein-Barr virus infection7.82E-0413P13765, P01106, Q13547, O00463, P10415, P07948, Q13761, P24522, O60603, P29728, P07766, P09693, P20963HLA-DOB, MYC, HDAC1, TRAF5, BCL2, LYN, RUNX3, GADD45A, TLR2, OAS2, CD3E, CD3G, CD247More
Revefenacinhsa05202Transcriptional misregulation in cancer2.67E-0415Q13315, P41732, P14780, P27930, Q15744, Q16548, Q13077, O15550, P08069, P35226, P05164, P12838, P08246, Q9C0K0, P24522ATM, TSPAN7, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, UTX, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45AMore
Revefenacinhsa05205Proteoglycans in cancer3.48E-021P08069IGF1RMore
Revefenacinhsa05214Glioma9.95E-031P08069IGF1RMore
Revefenacinhsa05215Prostate cancer1.33E-021P08069IGF1RMore
Revefenacinhsa05218Melanoma6.63E-031P08069IGF1RMore
Revefenacinhsa05224Breast cancer1.49E-021P08069IGF1RMore
Revefenacinhsa05225Hepatocellular carcinoma1.33E-021P08069IGF1RMore
Revefenacinhsa05235PD-L1 expression and PD-1 checkpoint pathway in cancer9.93E-0710O95267, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4More
Revefenacinhsa05310Asthma1.92E-023P13765, P12724, P01375HLA-DOB, RNASE3, TNFMore
Revefenacinhsa05321Inflammatory bowel disease6.95E-077O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21RMore
Revefenacinhsa05323Rheumatoid arthritis2.19E-024P13765, P10747, P09341, O60603HLA-DOB, CD28, CXCL1, TLR2More
Revefenacinhsa05332Graft-versus-host disease2.87E-055P13765, P10747, P01375, P26715, Q13241HLA-DOB, CD28, TNF, KLRC1, KLRD1More
Revefenacinhsa05340Primary immunodeficiency2.19E-024P01730, P01732, P07766, P06239CD4, CD8A, CD3E, LCKMore
Revefenacinhsa05412Arrhythmogenic right ventricular cardiomyopathy4.48E-021P54284CACNB3More
Revefenacinhsa05414Dilated cardiomyopathy4.55E-022P54284, P26678CACNB3, PLNMore

Community members of Revefenacin (SDC: 5.41)

UniProtACGene NameProtein NameReported/
Predicted
DisGeNETSPVSdrugabilitySHiSBiNSDisG
Q96RR4CAMKK2Calcium/calmodulinNonedependent protein kinase kinase 2Predicted00.36280.34060.46511.3277
P06213INSRInsulin receptorPredicted00.27940.78130.72092.4232
P06493CDK1CyclinNonedependent kinase 1Predicted00.01310.6042.6105
P09619PDGFRBPlateletNonederived growth factor receptor betaPredicted00.04960.94440.74082.6543
P08069IGF1RInsulinNonelike growth factor 1 receptorPredicted10.20820.95610.98833.0047
P06239LCKTyrosineNoneprotein kinase LckPredicted00.057610.72872.7575
P07948LYNTyrosineNoneprotein kinase LynPredicted00.0910.53190.6061.7154
P51813BMXCytoplasmic tyrosineNoneprotein kinase BMXPredicted00.05970.326300.6825
Q08881ITKTyrosineNoneprotein kinase ITK/TSKPredicted10.16350.55450.4221.6127
P42681TXKTyrosineNoneprotein kinase TXKPredicted00.28040.30260.19130.9367
P00734F2ProthrombinPredicted10.09630.7070.49771.9598
This pair is Reported in Drugbank.
Gene nameUniProt_IDBioactivityValue (nM)